Maxillary Sinus Augmentation With Xenogeneic Bone Graft Associated or Not With Fibrin Rich in Platelets and Leukocytes Produced by Horizontal Centrifugation: A Randomized Clinical Trial.

Dental Implants Clinical Trial

Official title:
Maxillary Sinus Augmentation With Xenogeneic Bone Graft Associated or Not With Fibrin Rich in Platelets and Leukocytes Produced by Horizontal Centrifugation for Early Implant Placement: a Randomized Controlled Split-mouth Clinical Trial.

Status Completed

Clinical Trial Summary

The objective of study is to evaluate the influence of the use of Platelet Rich Fibrin (PRF) from the patient's produced by a new horizontal centrifugation protocol associated with particulate xenogenous bone graft in the rehabilitation of atrophic maxillary sinus for early osseointegrated implants plancement. In a split-mouth model, twelve patients in need of rehabilitation with at least two bilateral implants in the regions of atrophic maxillary sinus will simultaneously undergo bone reconstruction using deproteinized particulate xenogenous bone (Bio-Oss Small®; Geistlich AG, Wolhusen , Switzerland). Randomly, one of the surgical sites of each patient will be reconstructed using the associated technique of solid PRF + Liquid PRF with the xenogen material, where at the end of the grafting procedure, both sites will be protected by a collagen membrane (Bio-Gide® Compressed; Geistlich AG, Wolhusen, Switzerland) positioned over the surgical access of the maxillary sinus. During the research, cone-beam computed tomography scans will be performed preoperatively, immediately after surgical procedure, 3 months after maxillary sinus reconstruction, after immediate implants placement and 12 months after functional load of the implants for comparative volume measurement of tissue gain and the maintenance of the grafted tissue. During the implant surgery, bilateral biopsies will be collected after 4 months of the regenerative surgical procedure during the early dental implants surgery by virtually guided surgery. The stability of the implants will be measured by means of resonance frequency analysis (ISQ) after the immediate postoperative period and 6 postoperative months as the clinical success rates of the implants after 12 months with functional load. The tissue samples will be used for histological, histomorphometric, immunohistochemistry and microtomographic analysis. All data obtained will be statistically analyzed.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05957705
Study type	Interventional
Source	University of Sao Paulo
Contact
Status	Completed
Phase	N/A
Start date	March 17, 2021
Completion date	July 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05466006` - Peri-implant Soft Tissue Volume Changes at Small Buccal Dehiscences	N/A
Withdrawn	`NCT00313989` - Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology	N/A
Completed	`NCT05081050` - Short Implants Supporting Single Crowns in the Posterior Region
Completed	`NCT04707677` - Comparative Aesthetic Analysis Between Titanium and Ceramic Implants	N/A
Recruiting	`NCT05989061` - PEEK Versus Titanium Customized Healing Abutments	N/A
Recruiting	`NCT05722041` - Soft Tissue Volume Changes in Posterior Socket Sealing Abutment.
Completed	`NCT05512845` - The Double Factor Technique: a Computer-guided Implant Surgery Technique for Fully Edentulous Patients
Recruiting	`NCT03837158` - Titanium Zirconium (TiZr) Mini Implants	N/A
Completed	`NCT01944267` - Procedures for Improving the Mucosa Around Implants	N/A
Completed	`NCT00971516` - Healing Profile of Titanium Dental Implants Placed in Patients With Diabetes	N/A
Completed	`NCT04305080` - Effect of Anodic Oxidation of Implant Abutment Collar on the Peri-implant Soft Tissue Health	N/A
Completed	`NCT06191510` - Xenogenic Bone Intentionally Left Exposed
Completed	`NCT04459494` - In the Treatment of Implants With Different Methods; Early Bone Loss and Patient Satisfaction	N/A
Recruiting	`NCT05644470` - Association of Implant Position and Crown Contour With Tissue Health
Completed	`NCT05101954` - Platelet Rich Fibrin and Concentrated Growth Factors on Osseointegration of Immediate Implants	N/A
Recruiting	`NCT05748379` - Atraumatic Zirconia Abutment Versus Customized Composite Healing Abutment in Maxilla or Mandible.	N/A
Recruiting	`NCT05627037` - Marginal Bone Level Around Titanium Implants Produced by Additive Manufacture	N/A
Enrolling by invitation	`NCT06187805` - Retrospective Case Series - OSSIX Volumax Collagen Xenograft Scaffolding
Recruiting	`NCT06100120` - A Triple-blinded Non-inferiority Multicentre Randomized Controlled Trial Comparing Hybrid and Fully Etched Implants P1	N/A
Recruiting	`NCT06155799` - Accuracy of Dynamic Navigation System on Zygomatic Implant Placement	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.